XML 14 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
ASSETS    
Cash and cash equivalents $ 12,787 $ 12,731
Restricted cash and equivalents 117,323 111,965
Finance receivables 1,522,085 2,304,984
Less: Allowance for finance credit losses (67,376) (109,187)
Finance receivables, net 1,454,709 2,195,797
Finance receivables measured at fair value 821,066 0
Furniture and equipment, net 1,837 1,752
Deferred tax assets, net 19,188 32,446
Accrued interest receivable 31,969 46,753
Other assets 26,801 23,397
Total 2,485,680 2,424,841
Liabilities    
Accounts payable and accrued expenses 31,692 28,715
Warehouse lines of credit 136,847 112,408
Residual interest financing 39,106 0
Securitization trust debt 2,063,627 2,083,215
Subordinated renewable notes 17,290 16,566
Total 2,288,562 2,240,904
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity    
Common stock, no par value; authorized 75,000,000 shares; 22,421,688 and 21,488,589 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively 70,273 71,582
Retained earnings 134,399 119,537
Accumulated other comprehensive loss (7,554) (7,182)
Total stockholders' equity 197,118 183,937
Total liabilities and stockholders' equity 2,485,680 2,424,841
Series A Preferred Stock [Member]    
Shareholders' Equity    
Preferred stock 0 0
Series B Preferred Stock [Member]    
Shareholders' Equity    
Preferred stock $ 0 $ 0